Home > Store > Management & Leadership

larger cover

Add To My Wish List

New Players in Life Sciences Innovation, The: Best Practices in R&D from Around the World, The

Register your product to gain access to bonus material or receive a coupon.

  • Description
  • Reviews
  • Sample Content

Product Author Bios

Tomasz Mroczkowski (Washington, DC) is full professor of International Business at American University's Kogod School of Business. He teaches international business and management in emerging economies in its MBA program, and teaches in the special masters program in biotechnology management at the ESCP-EAP business school in Paris, France. Mroczkowski researches innovation and business development in emerging economies, international outsourcing, and R&D globalization in the life science/biotech industries. He has been featured on NBC Nightly News, was interviewed by Tokyo Shinbun and Shinichi Shinbun, and contributed to The Asian Wall Street Journal and Japan Times.

The global center of gravity in life sciences innovation is rapidly shifting to emerging economies. In The New Players in Life Science Innovation, Tomasz Mroczkowski explains how China and other new economic powers are rapidly gaining leadership positions, and thoroughly assesses the implications. Mroczkowski discusses the sophisticated innovation strategies and reforms these nations have implemented: approaches that don't rely on market forces alone, and are achieving remarkable success. Next, he previews the emerging global "bio-economy," in which life science discoveries will be applied pervasively in markets ranging from health to fuels. As R&D in the West becomes increasingly costly, Mroczkowski introduces new options for partnering with new players in the field. He thoroughly covers the globalization of clinical trials, showing how it offers opportunities that go far beyond cost reduction, and assessing the unique challenges it presents. Offering examples from China to Dubai to India, he carefully assesses the business models driving today's newest centers of innovation. Readers will find up-to-date coverage of bioparks, technology zones, and emerging clusters, and realistic assessments of global R&D collaboration strategies such as those of Eli Lilly, Merck, Novartis, and IBM. With innovation-driven industries increasingly dominating the global economy, this book's insights are indispensable for every R&D decision-maker and investor.

 

Customer Reviews

1 of 1 people found the following review helpful
3.0 out of 5 stars A good concept lost to a lack of focus and shoddy editing, September 26, 2011
By 
Sreeram Ramakrishnan (Lynnfield, MA) - See all my reviews
(VINE VOICE)    (REAL NAME)   
This review is from: The New Players in Life Sciences Innovation: Best Practices in R&D from Around the World, The (FT Press Operations Management) (Hardcover)
Customer review from the Amazon Vine™ Program (What's this?)
The premise of the book is very interesting - how will R&D in a critical domain evolve based on the key emerging trends and what are the best practices in the new landscape. Unfortunately, the book fails to live up to the promise.

The first three chapters provide a very laborious, repetitive analysis of the emerging countries in life sciences. Based on various government reports and other observations, the author convinces the reader that the "usual suspects" of emerging markets (Brazil, India, China...) are involved in Life Sciences as well. Other than highlighting the role of Singapore as a key player - these three chapters does nothing to advance a reader's understanding of the changing landscape.

While the author outlines three key emerging trends - clinical trials, drug discovery and formation of technology clusters, they lack a discussion on how the author identified these three areas to focus on. The dependence on a PriceWaterCooper analysis on the future... Read more
Help other customers find the most helpful reviews 
Was this review helpful to you? Yes No


1 of 1 people found the following review helpful
5.0 out of 5 stars This is a very fine book, of general relevance to innovation and globalization, September 9, 2011
By 
This review is from: The New Players in Life Sciences Innovation: Best Practices in R&D from Around the World, The (FT Press Operations Management) (Hardcover)
Customer review from the Amazon Vine™ Program (What's this?)
This is first rate, within the limits of its aims. Those limits are that it is research-centered, focused on a specific industry and set of ecosystems, and descriptive rather than normative. It deserves a broader audience, which it is unlikely to get, primarily because of the absurdity of academic book publishing, where the very opposite of incentive pricing applies; the smaller the market, the higher the price, which reduces sales to the Average Reader and stiffs students in the case of textbooks and gouges college libraries for monographs and specialist works. At $49 hardback and $39 on Kindle, this won't be a best seller.

It merits a broad readership because it captures not just the dynamics of life sciences but of general shifts in global business in many other sectors. The analysis is well-grounded, full of data and examples that are instructive and embedded in a clear structure and set of organizing themes. It is very rich in illustrations from sectors, companies and... Read more
Help other customers find the most helpful reviews 
Was this review helpful to you? Yes No


1 of 1 people found the following review helpful
3.0 out of 5 stars Changing of the Guard, August 23, 2011
By 
This review is from: The New Players in Life Sciences Innovation: Best Practices in R&D from Around the World, The (FT Press Operations Management) (Hardcover)
Customer review from the Amazon Vine™ Program (What's this?)
After manufacturing, software and IT enabled services, now it is the time for the Life Science Industry to experience the effects of Globalization. Tomasz Mrockzkowski shows how R&D in life sciences is shifting from the Western countries to new global powerhouses like China and India. He compares the emerging innovation systems and national policies of China, India, Singapore, South Korea, and Brazil and evaluates their strengths and weaknesses in Pharmaceuticals, R&D, clinical trials and infrastructure creation. The critical study of the developments in differenct countries across the world gives not only very useful statistics, but also provides the framework for companies as well as entrepreneurs to take advantage of the global shifts in growth.

Strategies of the largest multinational pharmaceutical companies in their R&D collaborations with the developing world are explored in depth, which reveals how jobs as well as knowledge are now moving out from US and Europe to... Read more
Help other customers find the most helpful reviews 
Was this review helpful to you? Yes No


Share your thoughts with other customers:
 See all 9 customer reviews...

Online Sample Chapter

Power Shifts in Global R&D and Innovation: What They Mean for Firms in Life Science Businesses

Table of Contents

Acknowledgments     viii

About the Author     ix

Chapter 1 Power Shifts in Global R&D and Innovation: What They Mean for Firms in Life Science Businesses     1

Chapter 2 The Race for the Best National Innovation System: Who Has the Most Effective Strategy     37

Chapter 3 A Reshuffling of Markets and Growth Opportunities     73

Chapter 4 Improving R&D Productivity: Contract Research and Discovery Collaborations with the New Players as Solutions     109

Chapter 5 Globalization of Clinical Trials: It Is Not Just About Slashing Costs     151

Chapter 6 Accelerating Innovation: Bioparks, Technology Zones, and Emerging Clusters     193

Chapter 7 Company Strategies of Global R&D Collaborations: From West Meets West to West Meets East     229

Chapter 8 The Future: The Expanding Universe of Global Innovation     269

Endnotes     303

Index     331

Sample Pages

Download the sample pages (includes Chapter 1 and Index)

 
Best Value

Book + eBook Bundle  $119.98  $52.99

Book Price $47.99
eBook Price $5.00
eBook formats included

Buy

This book includes free shipping!

Buy

Book  $59.99  $47.99

Usually ships in 24 hours.

This book includes free shipping!

Buy

eBook (Watermarked)  $59.99  $47.99

Includes EPUB, MOBI, and PDF
About eBook Formats

This eBook includes the following formats, accessible from your Account page after purchase:

ePubEPUBThe open industry format known for its reflowable content and usability on supported mobile devices.

MOBIMOBIThe eBook format compatible with the Amazon Kindle and Amazon Kindle applications.

Adobe ReaderPDFThe popular standard, used most often with the free Adobe® Reader® software.

This eBook requires no passwords or activation to read. We customize your eBook by discretely watermarking it with your name, making it uniquely yours.

Purchase Reward: One Month Free Subscription
By completing any purchase on FT Press, you become eligible for an unlimited access one-month subscription to Safari Books Online.

Get access to thousands of books and training videos about technology, professional development and digital media from more than 40 leading publishers, including Addison-Wesley, Prentice Hall, Cisco Press, IBM Press, O'Reilly Media, Wrox, Apress, and many more. If you continue your subscription after your 30-day trial, you can receive 30% off a monthly subscription to the Safari Library for up to 12 months. That's a total savings of $199.